Genus plc (GENSF)
OTCMKTS · Delayed Price · Currency is USD
35.00
0.00 (0.00%)
At close: Dec 29, 2025
Genus Revenue
In the fiscal year ending June 30, 2025, Genus had annual revenue of 672.80M GBP with 0.60% growth. Genus had revenue of 336.40M in the half year ending June 30, 2025, a decrease of -0.91%.
Revenue
672.80M GBP
Revenue Growth
+0.60%
P/S Ratio
2.47
Revenue / Employee
210.91K GBP
Employees
3,190
Market Cap
2.28B USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 672.80M | 4.00M | 0.60% |
| Jun 30, 2024 | 668.80M | -20.90M | -3.03% |
| Jun 30, 2023 | 689.70M | 96.30M | 16.23% |
| Jun 30, 2022 | 593.40M | 19.10M | 3.33% |
| Jun 30, 2021 | 574.30M | 22.90M | 4.15% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Vaxart | 148.20M |
| Elite Pharmaceuticals | 122.89M |
| Zomedica | 29.45M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
Genus News
- 5 days ago - GNS Expands Educational Project in Bali with Genius City Initiative - GuruFocus
- 24 days ago - Genius Group (GNS) Pursues Dual Listing on Australian Securities Exchange - GuruFocus
- 4 weeks ago - GNS Executes Fourth Stock Buyback, Acquiring One Million Shares - GuruFocus
- 5 weeks ago - Genius Group (GNS) Boosts Bitcoin Holdings and Reports $1M Q4 Profit - GuruFocus
- 5 weeks ago - Genius Group (GNS) Boosts Bitcoin Holdings and Reduces Debt - GuruFocus
- 5 weeks ago - GNS Pursues Legal Action to Reinstate Buy Button for Investors - GuruFocus
- 2 months ago - Genius Group (GNS) Sponsors CoinDesk's Bitcoin Treasury Month - GuruFocus
- 2 months ago - GNS Sees Increased Investment from CEO Roger Hamilton - GuruFocus